Intrathecal Drug Delivery for Pain and Spasticity

Intrathecal Drug Delivery for Pain and Spasticity - a volume in the new Interventional and Neuromodulatory Techniques for Pain Management series - presents state-of-the-art guidance on the full range of intrathecal drug delivery techniques performed today. Asokumar Buvanendran, MD and Sudhir Diwan, M.D., M.S offer expert advice on a variety of procedures to treat chronic non-malignant pain, cancer pain, and spasticity. Comprehensive, evidence-based coverage on selecting and performing these techniques - as well as weighing relative risks and complications - helps you ensure optimum outcomes. With access to the fully searchable text at www.expertconsult.com, you’ll have the detailed visual assistance you need right at your fingertips. Table of Contents: SECTION I: General Considerations Chapter 1: Basic Science of Spinal Receptors Chapter 2: Pharmacologic Agents and Compounding of Intrathecal Drugs Chapter 3: Polyanalgesia for Implantable Drug Delivery Systems Chapter 4: Principles of Patient Management for Intrathecal Analgesia Chapter 5: Patient Selection for Intrathecal Infusion to Treat Chronic Pain Chapter 6: Patient Preparation Chapter 7: Psychological Considerations in IDD Chapter 8: Intrathecal Drug Delivery: Medical Necessity, Documentation, Coding and Billing   SECTION II: Implant Devices Chapter 9: Methods of Trials for Consideration of ITDDS Chapter 10: Techniques of Implant Placement for Intrathecal Pumps Chapter 11: Programmable versus Fixed-Rate Pumps for Intrathecal Drug Delivery Chapter 12: SynchroMed EL vs SynchroMed II Chapter 13: Minimizing the Risks of Intrathecal Therapy Chapter 14: Complications Associated with Intrathecal Drug Delivery Systems SECTION III: Evidence-based practice Chapter 15: Management of ITDDS in Patients with Co-Morbidities Chapter 16: Cost-Effectiveness of Implanted Drug Delivery Systems Chapter 17: Neuroaugmentation by Stimulation vs. Intrathecal Drug Delivery Systems Chapter 18: Anticoagulation guidelines and Intrathecal Drug Delivery Systems Chapter 19: Intrathecal Therapy for Malignant Pain SECTION IV: ITDDs for spasticity Chapter 20: Intrathecal Baclofen Trialing Chapter 21: Baclofen Pump Management SECTION V: Future of ITDDs Chapter 22: Future of Intrathecal Drug Delivery Systems (including new devices) Chapter 23: Trialing for Ziconotide Intrathecal Analgesic Therapy Chapter 24: Perioperative Management of Patients with ITDDS Asokumar Buvanendran , Associate Professor, Department of Anesthesiology Rush University Medical Center Chicago, IL ; Sudhir Diwan , Director of Pain Medicine, Department of Anesthesiology, Director of Quad-Institutional Pain Medicine Fellowship Program, Weill Cornell Medical College and Timothy Deer , MD, President and CEO, The Center for Pain Relief Clinical Professor of Anesthesiology, West Virginia University School of Medicine Charleston, West Virginia